The author's dual-acting compound addresses this issue: the NMDA receptor antagonist (MK-801) is only activated when the drug binds to and is internalized by the GLP-1 receptor
Aim for three small, balanced meals daily that include: Lean protein sources (chicken, fish, beans, lentils) to support satiety Complex carbohydrates (whole grains, vegetables) for sustained energy Healthy fats (olive oil, nuts, avocado) in moderate amounts Adequate fibre to support digestive health This approach aligns with the NHS Eatwell Guide and helps maintain stable blood glucose levels while providing essential nutrients, which may naturally reduce cravings for quick-energy foods like sweets
First-ever WHO guidelines recommending the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults has been issued by the World Health Organization in what the global health agency said is a conditional sign of approval for the cutting edge medications that have become widely popular
However, when you are taking a prescription medication like semaglutide, it is natural to wonder if you are still eligible to sit in that donor chair
We provide new evidence that treatment with semaglutide 2.4 mg weekly results in clinically relevant weight reduction
What is this hormone that has seemingly cured obesity overnight for so many